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Homologous gene targeting (HGT) is a precise but ineﬃcient process for genome engineering. Several methods for increasing its
eﬃciency have been developed, including the use of rare cutting endonucleases. However, there is still room for improvement, as
even nuclease-induced HGT may vary in eﬃciency as a function of the nuclease, target site, and cell type considered. We have
developed a high-throughput screening assay for the identiﬁcation of factors stimulating meganuclease-induced HGT. We used
this assay to explore a collection of siRNAs targeting 19,121 human genes. At the end of secondary screening, we had identiﬁed
64 genes for which knockdown aﬀected nuclease-induced HGT. Two of the strongest candidates were characterized further. We
showed that siRNAs directed against the ATF7IP gene, encoding a protein involved in chromatin remodeling, stimulated HGT by
a factor of three to eight, at various loci and in diﬀerent cell types. This method thus led to the identiﬁcation of a number of genes,
the manipulation of which might increase rates of targeted recombination.
1.Introduction
The transfection of cells with exogenous DNAcan be used to
generate stable transformants with the exogenous sequence
integrated into their genomes by random insertion (RI) or
targeted integration driven by homologous recombination.
In the case of homologous recombination, the integration
of DNA into the genome is referred to as “homologous
gene targeting” (HGT). Both RI and HGT depend on DNA
double-strand break (DSB) repair mechanisms.
DSBs are particularly hazardous events in cells. Two
diﬀerent and competing mechanisms repair DSBs. Homol-
ogous recombination (HR) involves the use of homologous
sequences as a template for restoring genomic integrity
upon DSB induction and is considered to be an error-free
mechanism. Genetic and biochemical studies have shown
that HR in yeast is mediated by the RAD52 epistasis group
of genes [1], which are required to various extents for
HGT. For example, almost no HGT is observed in the
absence of a functional RAD52 gene, but substantial levels
of recombination are observed in absence of RAD51 and
RAD57 [2]. Homologs of these genes have been identiﬁed
invertebrates,includingRAD51,RAD51B,RAD51C,RAD52,
RAD54, XRCC2,a n dXRCC3, which have been shown to be
necessary for HGT in the DT40 chicken lymphoid cell line
[3–7].Inmouseembryonicstem(ES)cells,HGTisdecreased
slightly by mutationsin BRCA2 [8], strongly by mutationsin
BRCA1 [9]a n dRAD54 [10] and is completely abolished by
mutationsinERCC1/XPF [11].Bycontrast,nonhomologous
end joining (NHEJ) requires little or no homology for DSB
repairandisoftenassociatedwithinsertions and/ordeletions
at the DSB site [12]. This mechanism is therefore considered
tobeerrorprone.SeveralfactorsinvolvedinNHEJhavebeen
identiﬁed, including the Ku DNA-binding heterodimers, the
DNA-PKcs protein kinase, Artemis, DNA ligase IV (Lig4),
and associated partners XRCC4 and XLF/Cernunnos [12].
These proteins diﬀer in their impact on the eﬃciency of
the NHEJ process, but the absence of XRCC4, Lig4, and Ku
strongly increases the proportion of error-associated DSB
repair events [13–16]. Early studies reported that Chinese2 Journal of Nucleic Acids
hamster cell lines with mutations in XRCC4 (xrs-1) or Ku80
(xrs-6) had lower random integration frequencies than the
wild type (WT) [17, 18]. Furthermore, mouse cells with a
mutant DNAligase IV were found to have signiﬁcantly lower
random integration frequencies than WT cells [19]. Finally,
Ku80 and DNA ligase IV deﬁciencies in plants lead to defec-
tiveT-DNAintegration[20].All theseﬁndings are consistent
witharoleforNHEJinrandomintegrationevents.However,
the precise mechanism of random integration remains to be
determined.
HGT provides the ultimate genetic tool for investigating
gene function, as it can be used for the speciﬁc modiﬁcation
of almost any genomic sequence. Moreover, HGT may
provide an alternative approach for gene therapy strategies,
because targeted integration into a genomic safe harbor may
reducethe risks of insertional mutagenesis. However, the low
frequency of homologous gene targeting has been a major
obstacle to the use of this technology. Indeed, random inte-
gration appears to be the major DNA integration pathway in
most organisms, including mammals and higher plants (for
review, see [21]), with the exception of S. cerevisiae and a
handful of other species and cell types. Several reports have
also indicated that HR is eﬃcient essentially during the late
S and G2 phases of the cell cycle [22–29], suggesting that it
may be diﬃcult to make use of HGT in postmitotic cells.
Various approaches have been tested for improving
genetargeting performances. Selectionprocedureshavebeen
used, to eliminate unwanted random integration [30, 31].
However, although these methods increase the yield of
targeted events in transformants, they have no impact on
absolute gene targeting frequencies—the number of targeted
events per transfected cell. Many other studies have aimed
to increase the eﬃciency of HR. One of the most successful
methods in current practice is based on the use of rare
cutting endonucleases, such as meganucleases or zinc ﬁnger
nucleases (ZFNs) to induce a DSB in the targeted gene
[21]. Meganucleases are natural endonucleases that induce
targeted recombination in living cells [32, 33], whereas
ZFNs are generated by fusing a zinc ﬁnger-based DNA-
binding protein with the catalytic domain of the bacterial
FokI endonuclease [34–36]. Robust stimulation of HGT by
a factor of 100, or even 1000, has been achieved by several
groups in this way, resulting in several percents of targeted
events in immortalized cells [37–41] .H o w e v e r ,t h ed e g r e eo f
stimulation achieved is highly variable and depends on the
nuclease [37] and other factors. For example, a zinc ﬁnger
protein recognizing a sequence present in the plant SurA
and SurB genes has been shown to induce diﬀerent levels of
targeted mutagenesis in these two genes [38], suggesting that
target accessibility or the eﬃcacy of a DNA repair pathway
may be locus-dependent. The eﬃciency of the process also
depends on cell type: by using nonintegrative lentiviral
vectors rather than transfection, Lombardo et al. induced up
to 50% HGT events at the CCR5 locus in K562 and Jurkat
cells, about 5% in ES cells, and almost 0.1% in CD34+ cord
blood progenitor cells [37]. Similarly, Zou et al. achieved
muchlowerlevelsofDSB-inducedrecombinationatthePIG-
A locus in human ES cells and induced pluripotent stem
cells (iPS) (2–4 × 10
−4 and ×10
−5,r e s p . )t h a ni n2 9 3c e l l s
(3%) [40]. These diﬀerences may be due to lower eﬃciencies
of vectorization and/or nuclease expression, diﬀerences in
the likelihood of homologous recombination in diﬀerent
cell types, or a combination of these factors. Nevertheless,
there is still room for improvement. Given the cell cycle
dependence of homologous recombination, Urnov et al. and
others have induced simple reversible cell cycle arrest in the
G2 phase with reagents such as vinblastine, resulting in a
small but signiﬁcant increase in nuclease-induced HGT in
immortalized cell lines [38, 39].
Another approach involves direct modulation of the
cellular DNA repair machinery. Several groups have adopted
this strategy and have tried to stimulate HGT by overpro-
ducing DNA repair proteins [42–46]. Overexpression of the
human RAD51 gene resulted in a two to three times increase
in HGT [43], but higher rates (10 to 64 times higher) have
been reported in other studies involving overproduction of
the bacterial RecA [44]o ry e a s tR a d 5 2[ 46]p r o t e i n si n
mammalian cellsorofyeast Rad54in Arabidopsis [45].Other
groups have investigated the impact of NHEJ inhibition on
HGT, with conﬂicting results in some cases. Pierce et al.
observed that HGT frequencies were similar in wt, Ku70−/−,
DNA-PK−/−,a n dXrcc4−/− mouse ES cells [47]. Similarly,
Dom´ ınguez-Bendala observed a similar absence of HGT
stimulation in Ku80-a n dDNA-PK-deﬁcient cells, although
they did observe a signiﬁcant increase in HGT following the
knockdown of PARP-1, an unrelated gene [48]. By contrast,
downregulation of the Ku70 and XRCC4 genes by siRNAs
in human cells leads to signiﬁcant 30 times increase in the
HGT/RI ratio at the HPRT locus [49].
By combining the use of a nuclease to create a DSB
in the targeted gene and the modulation of speciﬁc genes,
it should be possible to achieve the synergistic stimulation
of HGT. Various studies have shown that the eﬃciency of
homologous recombination induced by a nuclease could
further beenhanced bytheoverproductionorinactivation of
DNA repair proteins [47, 50, 51], although all these studies
involved the ap r i o r iidentiﬁcation of potential candidates
on the basis of their role in DNA repair. Several genome-
wide RNAi screening analyses have recently improved our
understanding of the DNA repair pathway [52–54]. Słabicki
et al. identiﬁed 61 genes aﬀecting DNA DSB repair in
human HeLa cells [54]. The downregulation of 17 of
these genes led to an increase in endonuclease-induced
homologous recombination. However, this study assessed
intrachromosomal recombination rather than gene targeting
per se (recombination between an exogenous DNA sequence
and a target chromosomal locus). It therefore seems likely
that many other genes may be involved in the DSB-induced
HGT mechanism.
We have developed a high-throughput screening system
for a genome-wide study of factors aﬀecting nuclease-
induced HGT. Using an assay monitoring the HGT induced
by the I-SceI meganuclease, we screened a library of siRNAs
and identiﬁed several genes for which downregulation was
associated with a signiﬁcant increase in HGT eﬃciency.
Sixty-four candidates were conﬁrmed by secondary screen-
ing. Two of these candidates, EP300 and ATF7IP,w h i c h
are not known to be directly involved in DNA repair, wereJournal of Nucleic Acids 3
characterized further. We show here that the downregulation
of these genes leads to a signiﬁcant increase in the frequency
of HGT at endogenous loci in human cells.
2.Materialsand Methods
2.1. Cell Culture. The GM00847, cGPS HEK-293, and 293H
cell lines were cultured in Dulbecco’s modiﬁed Eagle’s
medium (dMEM) plus Glutamax supplemented with 10%
fetal calf serum, 2mM L-glutamine, 100IU/ml penicillin,
100μg/ml streptomycin, and 0.25μg/ml amphotericin B
(Fungizone) at 37◦, under an atmosphere containing 5%
CO2. cGPS HEK-293 cells were grown in the presence of
0.1mg/ml hygromycin B (Sigma). The E2 clone for the
measurement of I-SceI-induced gene targeting with the
luciferase reporter system was selected and maintained on
400 and 250μg/ml G418, respectively. Finally, the clone
used for measuring I-SceI-induced gene targeting with the
GFP reporter system was selected on 400μg/ml G418 and
0.4μg/ml puromycin. For cellular expansion, this clone was
maintained in medium containing 200μg/ml G418 and
0.2μg/ml puromycin.
2.2. Generation of Cell Lines for Primary and Secondary
Screening. For primary screening, we generated a cell
line derived from GM00847 (Coriell Institute) carrying a
luciferase-based reporter gene, as described in Figure 1(a).
We electroporated 106 GM00847 cells with 500ng of the
gene-targeting substrate plasmid (Figure 1), linearized by
PvuI digestion. Electroporation was carried out with the
Amaxakit,accordingtothemanufacturer’s instructions.Two
days after transfection, 400μg/ml G418 were added to the
cells. The selected clones were then ampliﬁed for genomic
DNAextraction,forSouthernblotstodeterminewhetherthe
transgene was present as a single copy.
For secondary screening, we generated a cell line derived
from cGPSHEK293 (Cellectis Bioresearch, Romainville,
France) carrying a GFP-based reporter gene, as described
in Figure 3(a).W eu s e d1 0 6 cells to seed 10 cm tissue
culture dishes on the day before transfection. We cotrans-
fected cells with 3μg of gene targeting substrate and 2μg
of I-CreI expression plasmid using Lipofectamine 2000
reagent (Invitrogen), according to the manufacturer’s in-
structions. Twenty-four hours after transfection, the culture
medium was replaced with fresh medium supplemented
with 0.4mg/ml G418. After 12 days of selection, the second
selective agent, puromycin, was added at a concentration
of 0.4μg/ml. After incubation for seven to nine days in
the presence of both selective agents, single-colony clones
were picked in 96-well plates. Double-resistant clones were
analyzed by Southern blotting for integration at the I-CreI
locus (data not shown).
2.3. Screening Assays. Forprimary screening, 14,000cells per
well were seeded in white 96-well plates on the day before
transfection. Cells were transfected with 200 ng of Luciferase
Repair Matrix and I-SceI induction plasmid (RMLuc+I-SceI
see Figure 1(b)) per well or with Luciferase Repair Matrix
alone (RMLuc, see Figure 1(b)), with or without 33nM
siRNA, in the presence of 0.8μlo fP o l y f e c tt r a n s f e c t i o n
reagent (Qiagen). We added 50μlo fO N E G l o( P r o m e g a )t o
each well, 72 hours after transfection, and incubated the cells
in the dark for 3 minutes before luciferase activity analysis
(1 second/well) with a PHERAStar luminometer (BMG
Labtech). For secondary screening, 15,000 and 106 cells
were seeded in 96-well plates or 10cm dishes, respectively,
on the day before transfection. Cells were transfected with
200ng (for 96-well plates) or 5μg( f o r1 0 c md i s h e s )o f
RMGFP+ISceI (Figure 3) with or without siRNA at a ﬁnal
concentration of 33nM, using 1.35μla n d9 0μlo fP o l y f e c t
transfection reagent, respectively. Cells were trypsinized
96 hours after transfection, and the percentage of GFP-
positive cells was monitored by ﬂow cytometry (Guava
Instruments). We monitored siRNA transfection eﬃciency
with rhodamine-labeled siRNAcoupledwith ﬂow cytometry
detection. Transfection eﬃciency reached 73%, indicating
that the transfection conditions used were very good (data
not shown). The ratio of the percentage of GFP+ cells for
as p e c i ﬁ cs i R N Ao v e rt h a tf o rt h es i R N Ac o n t r o lA l lS t a r
(AS Qiagen) was used to determine the stimulation factor
for each speciﬁc siRNA. The potential eﬀect of siRNAs was
assessed by applying Student’s t-tests to the stimulation
factor. Two controls siRNAs were used to validate siRNA
transfection: the RAD51 and GFP siRNAs. The RAD51 and
GFP siRNAs decreased the percentage of EGFP-positive cells
by factors of six and four with respect to the control All
Star (AS) siRNA, demonstrating that the siRNAs were active
(Figure 4). All experiments carried out in 96-well plates
(cell seeding, cell transfection, incubation, and luciferase
detection)wereperformed withaVelocity11robot(Velocity,
Palo Alto, CA). Z-scores were calculated with the following
equation, Z = (x − μ)σ−1,w h e r ex is the mean luciferase
signal for a given siRNA, μ is the mean luciferase signal
for the run, and σ is the standard deviation of the run.
Means and standard deviations were calculated excluding
controls.
2.4. Targeted Integration at the hRAG1 Locus. On the
day before transfection, 106 293H cells were seeded in
10cm dishes. Cotransfection was performed with 3μgo f
meganuclease expression plasmid, 2μgo fK n o c k - I nm a t r i x ,
and 33nM siRNA, in the presence of 90μl of Polyfect.
The Knock-In plasmid has all the necessary characteristics
favoring highly eﬃcient homologous recombination at the
endogenous hRAG1 locus in 293H cells. The left and right
arms correspond to isogenic sequences of 2kb and 1.2kb
in size, respectively, surrounding the RAG1 meganuclease
recognition site. These two homologous arms are separated
by a heterologous 1.7kb fragment [55].
Twenty-four hours after transfection, cells were trypsi-
nized and seeded in 96-well plates at a density of 10 cells
per well. Two weeks after transfection, genomic DNA was
extracted with the ZR96 Quick-gDNA kit (Zymo Research),
according to the manufacturer’s protocol. We screened for
knock-in events by PCR, as described by Grizot et al. [55],4 Journal of Nucleic Acids
Luc2 pEF1a pA pA
RMLuc
RMLuc pCMV-I-SceI
1kb 1kb
I-Scel
pSV N´ eo
Intron
EF1α
(a)
siRNA AS
siRNA Lig4
siRNA Rad51
0
200
400
600
pUC RMLuc
+
I-SceI
R
L
U
0
30
600
900
RMLuc pUC RMLuc
+
I-SceI
R
L
U
(b)
Rad51
Nonspeciﬁc
03 8 4 8 6 7 2 PM
20
30
50
40
60
Time after
transfection (h)
(c)
Figure 1:A cell-based assayforidentifying factors stimulatingI-SceI-induced HGT. (a)A reporter system forI-SceI-induced gene targeting.
The ﬁreﬂy luciferase gene (Luc2) is inactive due to replacement of the ﬁrst 22 base pairs (bp) by a 24 bp I-SceI site (vertical black box).
T h ep l a s m i d sc o n s t r u c t e df o rI - S c e I - i n d u c e dg e n et a r g e t i n ga r ed e s cribed as follows: RMLuc+I-SceI has (i) the ﬁrst 22bp of the luciferase
gene surrounded by 1kb of homologous sequence (hatched boxes); (ii) an I-SceI induction cassette under the control of a CMV promotor.
The RMLuc plasmid does not contain the I-SceI expression cassette. (b) Validation of the cell-based assay. The E2 cell line carrying a single
integrated copy of the reporter system described in (a) was transfected with empty vector (pUC), RMLuc, or RMLuc+I-SceI (left panel).
Luciferase activity was analyzed 72 hours after transfection. The E2 cell line was also cotransfected with either pUC or with RMLuc+I-SceI
plus siRNAs known to modulate gene targeting (right panel): RAD51 siRNA and LIG4 siRNA. The results obtained were compared with
those for cotransfection with the control All Star (AS) siRNA. Luciferase activity was assessed 72 hours after transfection. (c) Western blot
analysis of Rad51 protein levels at various times after transfection, for the E2 clone with RMLuc+I-SceI and RAD51 siRNA. Speciﬁc and
nonspeciﬁc bands were detected at 30 and 50kDa, respectively.Journal of Nucleic Acids 5
using oligonucleotides F2: 5 -AGGATCTCCTGTCATCTC-
AC-3  and R12: 5 -CTTTCACAGTCCTGTACATCTTGT-
3 . The percentage of knock-in events was calculated, taking
intoaccounttheplatingeﬃciencyfortransfected cells, which
was estimated at 30% (data not shown).
2.5. Targeted Integration at the hXPC4 Locus. On the day
before transfection, 106 293H cells were used to seed 10cm
dishes. Cotransfection was performed with 3μgo fm e g a -
nuclease-encoding plasmid, 2μg of Knock-In matrix, and
1nM siRNA,using 25μl of Lipofectamine 2000, according
to the manufacturer’s protocol. The Knock-In plasmid for
the XPC 293H endogenous locus has left and right arms
corresponding to isogenic sequences of 1.6kb and 1.5kb
in size surrounding the hXPC4 meganuclease recognition
site. These two homologous arms are separated by a 4.7kb
heterologous fragment of DNA containing a functional neo-
mycin resistance gene underthe control of a CMVpromoter.
The cells were trypsinized 72 hours after transfection, and
2000cellsperplate were used toseed 10cmdishes. One week
after seeding, we added 400μg/ml G418 to the cells. One
week later, G418-resistant clones were picked and ampliﬁed
in 96-well plates. Genomic DNA was extracted with the
ZR96 Quick-gDNA kit (Zymo Research), according to the
manufacturer’sprotocol.Thepercentageoftargetedeventsin
stabletransformants was analyzed byPCRscreening with the
oligonucleotides F3: 5 -CAAGCACCATAACAAACAACA-
TTGA-3  and R1: 5 -ATCCGAAAATGGATATACAAG-
CTC-3  (cf. Figure 7).
2.6. Western Blot Analysis. All stages of protein extract
preparation were carried out at 4◦. Cells were washed with
PBS, suspended in RIPA lysis buﬀer with 2mM PMSF,
1mM orthovanadate sodium,and proteaseinhibitorcocktail
(Santa Cruz) and incubated for 30 minutes on ice. Extracts
were centrifuged at 15,000g for 30 minutes. The supernatant
was retrieved, and its protein concentration was determined
with the BCA protein assay. Boiled protein extract (25μg)
was subjected to SDS-PAGE in a 10% polyacrylamide gel.
After migration, the proteins were electrotransferred to
nitrocellulose membrane and probed with speciﬁc antibod-
ies: anti-Rad51 (Oncogene Research) and antirabbit HRP
(SantaCruz)antibodies.Antibodybindingwasdetectedwith
the Luminol detection kit (Santa Cruz).
2.7. RNA Analysis. We suspended 5 × 106 cells in 1ml of
TRIzol (Invitrogen) and incubated them for ﬁve minutes.
We then added 200μl of chloroform, and the extracts
were centrifuged at 12000 × gf o r2 0m i n u t e sa t4 ◦.
The supernatant was retrieved. RNA was precipitated by
adding one volume of 75% ethanol and puriﬁed with the
PureLink RNA Micro kit (Invitrogen) according to the
manufacturer’s protocol. Reverse transcription was carried
out on 500ng of RNA, with the SuperScript III system
(Invitrogen). PCR was performed with 1μlo ft h eR T
products, with the following oligonucleotides: for EP300,
Forward, 5 -CTTGTTCACAAACTCGTCCAAGCC-3  and
Reverse 5 -TGTGATGGGAACTGAGTCTGAGG-3 ;f o r
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Figure 2: Representation of a typical primary screening run.
Fourteen 96-well plates containing siRNAs for the screen and
control siRNAs were transfected with RMLuc+I-SceI or pUC in
duplicate. Seventy-two hours after transfection, luciferase activity
was detected. Each dot represents the mean value per siRNA. The
blackboxshowstheluciferasevalueobtainedfollowingtransfection
with the empty vector (pUC), corresponding to background. Black
triangles represent the values obtained for cotransfection with the
AS siRNA and RMLuc+I-SceI; white circles represent the values
obtained for cotransfection with RAD51 siRNA and RMLuc+I-
SceI. Finally, white squares represent the values obtained for
cotransfection with LIG4 siRNA and RMLuc+I-SceI. The black line
indicates the mean value for the run. Dashed boxes show the cutoﬀ
values for hit deﬁnition.
ATF7IP, Forward 5 -TGCCAAAAGAAGCCTTTCTGGTCC-
3  and Reverse 5 -TCAAATACAGCACACTGCAGCGC-3 ;
for GAPDH, Forward 5 -ATCATCTCTGCCCCCTCTGCT-
GATGCCCCC-3  and Reverse 5 -GATGACCTTGCCCAC-
AGCCTTGGCAGCGCC-3 ; for I-SceI, Forward 5 -TAA-
TGAACCTCGGTCCGAACTCTAAACTGC-3  and Reverse
5 -AATTTGTTACGCAGACCCTTAACCAGG-3 .P C Rw a s
stopped during the exponential phase of ampliﬁcation, at
24 cycles, and the reaction mixture was loaded onto a 1%
agarose gel. PCR products were quantiﬁed with ImageJ
software.
3.Resultsand Discussion
3.1. Development of a High-Throughput Screening Assay. We
developed a cell-based functional assay amenable to high-
throughput screening for genome-wide screening for factors
aﬀecting nuclease-induced HGT. We constructed a reporter
system based on an inactivated ﬁreﬂy luciferase gene,
with HGT targeting this gene restoring readily detectable
luciferase activity (Figure 1(a)). As luciferase inactivation
resulted from the replacement of the ﬁrst 22bp of the
gene with an I-SceI target site, HGT could be induced by
expression of the meganuclease. This reporter construct was
stably introduced into the genome of the human GM00847
cell line, and a clone carrying a single-copy insertion was
identiﬁed by Southernblot analysis (datanot shown). Under
our experimental conditions (see Section 2), we detected no
activation of the luciferase gene in cells transfected with
the repair matrix alone, indicating that classical HGT was
not detectable in these conditions. By contrast, transfection6 Journal of Nucleic Acids
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Figure 3: Cell-based assay for secondary screening. (a) Reporter system. The transgene used to assess I-SceI-induced gene targeting is
integrated into the cGPS HEK-293 locus by expression of the I-CreI meganuclease. This transgene contains 1860bp of the EF1α human
promoter sequence, followed by (i) a puromycin cassette (used for selection), (ii) an IRES sequence, (iii) a GFP gene inactivated by the
insertion of an I-SceI site generating a stop codon, (iv) a neomycin resistance sequence (used for selection) under the control of a CMV
promoter.RepairplasmidandI-SceIinduction(RMGFP+I-SceI)andrepairplasmidalone(RMGFP)usedfortheinductionofgenetargeting
by I-SceI are shown in the following, with the length of homologous sequence indicated. GFP reporter gene expression is assessed by ﬂow
cytometry for the quantiﬁcation of gene targeting eﬃciency. (b) A clone resistant to both puromycin and neomycin was cotransfected with
RMGFP+I-SceI or RMGFP, with or without siRNA, or with the following siRNAs: AS, LIG4, RAD51,a n dGFP. GFP was detected by ﬂow
cytometry 96 hours after transfection. The results of four independent experiments are presented.
with a plasmid containing the repair matrix and an I-SceI-
expressing cassette increased luciferase activity by a factor of
30 (Figure 1(b)).
For further validation of our assay, we cotransfected
cells with the plasmid containing the repair matrix and
the meganuclease-encoding cassette, together with an siRNA
targetingthehumanRAD51gene(Figure 1(b)).Asanegative
control, we used an siRNA with no known human targets
(siRNA All STAR (AS) from QIAGEN). The RAD51 siRNA
eﬀectively knocked down the expression of its cognate target
gene, as shown in Figure 1(c). As expected, it strongly inhib-
ited (byafactor ofsix) I-SceI-inducedHGT. The knockdownJournal of Nucleic Acids 7
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Figure 4: Hits selected after secondary screening. Cells were cotransfected with 200ng of RMGFP+I-SceI and a panel of diﬀerent siRNAs,
as indicated, at a ﬁnal concentration of 33nM. GFP ﬂuorescence was detected by ﬂow cytometry 96h after transfection. The results are
expressed as the stimulationfactor, corresponding to the ratio of the percentage of GFP-positive cells in the presence ofthe siRNA hit to that
followingtransfection with the control siRNA (AS). Four independent experiments were performed and Student’s t-tests were used to assess
the signiﬁcance of diﬀerences in stimulation factor (P value < .05). Two siRNA controls were used to validate siRNA transfection: RAD51
and GFP siRNAs. The RAD51 and GFP siRNAs decreased the percentage of GFP-positive cells by factors of 6 and 4 with respect to the AS
control siRNA, demonstrating that the siRNAs were active.8 Journal of Nucleic Acids
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Figure 5: Characterization of EP300 and ATF7IP knockdown.
Total RNA was extracted 48 hours after transfection with the
indicated DNAs and siRNAs (two diﬀerent siRNA sequences were
used to target each of the ATF7IP and EP300 genes). RT-PCR was
carried out to amplify mRNA transcribed from the ATF7IP, EP300,
GAPDH,a n dI-SceI genes. The eﬀects of siRNAs on their targets
were monitored by analyzingband intensity after electrophoresis in
1% agarose gels. Lane1, untransfected cells. In lanes 2 to 7, the cells
were transfected with the plasmid carrying the repair matrix and
the I-SceI expression cassette. Lane 2, no siRNA; lane 3, AS siRNA;
lanes 4 and 5, siRNA against EP300; lanes 6 and 7, siRNA against
ATF7IP.
of NHEJ genes has been shown to stimulate DSB-induced
recombination between chromosomal repeats [47, 51, 54].
By contrast, conﬂicting data have been obtained regarding
the impact of NHEJ genes on classical HGT [48, 49]. We
thus investigated the impact of an siRNA targeting the LIG4
gene.Inourpreliminary experiment,consistentwitharecent
RNAi study [54], the LIG4 siRNA was shown to increase
HGTbyafactoroftwo(Figure 1(b)).Altogethertheseresults
conﬁrm the relevance of our experimental system for use in
the search for factors aﬀecting HGT.
3.2. Screening of a Genome-Wide Collection of siRNAs. We
used our assay to screen a collection of siRNAs targeting
19,121 human genes (Qiagen). This collection included two
individual siRNAs per gene, to overcome the problems of
highfalse-positive andfalse-negative hitratesassociated with
siRNA pools and to improve conﬁdence that the observed
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Figure 6: Impact of EP300 and ATF7IP knockdown on the
frequency oftargeted integrationattheendogenousRAG1 locus.(a)
Experimental design.(b) Results. Meanstimulationoftargeted inte-
gration events. The stimulation factor is expressed with respect to
control siRNA (AS). Data were obtained from 4 and 3 independent
experiments with EP300 siRNA and ATF7IP siRNA, respectively.
hits were due to silencing of the intended genes. The quality
of the runs was monitored by introducing siRNAs targeting
the human RAD51 and LIG4 genes into each 96-well plate as
positive controls. A typical experiment is shown in Figure 2.
T h el u c i f e r a s es i g n a li n c r e a s e df r o m6 5± 15 RLU, in cells
transfected with an empty vector (pUC), to 2000 ± 400 RLU
following cotransfection with the plasmid containing the
repair matrix and an I-SceI-expressing cassette and with the
AS control siRNA. In this experiment, transient deﬁciencies
of LIG4 and RAD51 genes resulted in luciferase signals of
3000±450 and 550±100 RLU, respectively. For all controls,
the coeﬃcient of variation (CV = σ/m,w h e r eσ is the
standard deviation and m the mean of the measured values)Journal of Nucleic Acids 9
was found to be below 20% (19%, 15%, and 19% for AS,
LIG4,a n dRAD51, resp.) demonstrating the quality of the
run. However, this level of variation is suﬃcient to have
as i g n i ﬁ c a n te ﬀect on the scoring of an siRNA as positive
or negative. Therefore, we decided to use a stringent cutoﬀ
point, to prevent the selection of too many false positives:
siRNAs were considered as potential candidate stimulators
of HGT if their Z-score was higher than 3. The drawback
of this strategy is the risk of a high rate of false negatives.
Indeed under this condition, whereas transient LIG4 gene
knockdownconsistentlyledtothestimulationofHGT(1.4±
0.3), it was scored as a positive hit in only 9 of the 35
runs required to screen the entire siRNA collection (data
not shown). However, the RAD51 siRNA, which decreased
HGT by a factor of six, resulted in weak signal, clearly
diﬀerent from the mean value of the run. These results
illustrate the limits of our current screening system, which
can easily miss factors having a modest eﬀect on HGT.
Moreover, the optimal timing between mRNA knockdown
and the resulting phenotype may vary as a function of the
gene targeted, cell type, siRNA sequence, metabolic pathway
and meganuclease expression. The cotransfection strategy
of siRNA and meganuclease-encoding vector could lead to
a partial extinction of the targeted protein, whereas the
meganuclease is at its optimum activity. However, it has
been shown that treatment with siRNA targeting Ku70 and
Xrcc4 reduced corresponding protein levels by 80–90% 48h
after transfection, with a return to normal levels by 96h
in HCT116 cell line (Bertolini, 2007 no. 7). Therefore, it is
reasonable to think that cotransfection strategy is applicable,
but it may underestimate the signiﬁcance of the genes. Thus,
although our primary screening assay was conducted with
siRNAstargetingmostoftherelevanthumangenes,itshould
actually be considered far from exhaustive.
Nevertheless, we eventually identiﬁed 290 candidates,
targeting 279 diﬀerent genes, from 38,242 (2 × 19,121) siR-
NAs, and these candidates were then subjected to secondary
screening (see the following). Several potential inhibitors of
HGT were also identiﬁed, and a series of siRNAs targeting
348 diﬀerent genes gave levels of inhibition at least similar to
the RAD51 siRNA (signal lower than the mean signal with
RAD51 siRNA plus half its standard deviation). However,
despite their important potential applications in medical
ﬁelds such as cancer treatment, siRNAs involved in the
inhibition of HGT were not the focus of this study and were
not processed by secondary screening.
3.3. Secondary Screening. High-throughputsiRNA screening
can lead to high false-positive rates. This problem was
addressed in our experimental procedure by systematic
duplication of the assay and the choice of a stringent cutoﬀ
point.However,we neverthelessdesigned an additionalassay
for secondary screening. We used the cGPS HEK-29 Full Kit
(Cellectis, France) to create a cell line derived from HEK293
and carrying a single copy of the GFP coding sequence
inactivatedbytheintroductionofanI-SceIsite(Figure 3(a)).
Like the GM00847 derivative used in primary screening, this
cell line can be used to monitor I-SceI-induced HGT. By
contrast to the primary screening, this secondary screening
method did not measure the global activity of a reporter
gene (luciferase) in the cell population. Instead, we deter-
mined the number of cells that had acquired a functional
GFP reporter gene using ﬂow cytometry detection. Thus,
siRNAs resulting in the mere enhancement of reporter gene
expression should be counterselected at this step. Moreover,
the two strains diﬀer in terms of parental cell type, reporter
gene, and integration locus. In this new cell line, HGT at
the GFP locus was not detectable in the absence of I-SceI
but was strongly stimulated when a meganuclease-encoding
cassette was introduced with the repair matrix (Figure 3(b)).
Consistent with our previous observations, transient RAD51
deﬁciencies inhibited gene targeting eﬃciency by factors of
4, while LIG4 siRNA had only a mild eﬀect, stimulating
HGT by a factor of 1.4 showing that this siRNA did not lead
to a strong and robust stimulation of I-SceI-induced HGT
frequency.
The 290 candidate siRNAs previously identiﬁed were
tested in this new system. Sixty-six were conﬁrmed as having
as i g n i ﬁ c a n t( P<. 05) stimulatory eﬀect, increasing HGT
by factors of 1.2 to 3 over the siRNA control (AS). These
66 candidates corresponded to 64 diﬀerent candidate genes,
with the ATR and EP300 genes each targeted by two diﬀerent
siRNAs (Figure 4). For eight genes (ATF7IP, DCDC2, EP300,
ATR, SERPINB2, SPRED3, UREB1,a n dFLJ35695),H G T
rates were more than doubled. None of the genes identiﬁed
in our study was found in an esiRNA screening that was
monitoring DSB-induced intrachromosomal homologous
recombination [54]. Many factors may account for such
discrepancies: cell type, the sequence and strength of the
siRNA, and the nature of the events involved. Indeed, in our
model, accessibilityoftheexogenousDNArepairtemplateto
the double-strand break site may be a major factor that was
not addressed in this previousstudy since the repair template
is present on the same chromatin. Therefore, our screening
might identify gene involved not directly in HR mechanism
but rather in regulation of HR such as the accessibility of
themeganuclease and/ortheexogenousDNAtemplatetothe
cleavage site.
To conﬁrm our data and rule out possible oﬀ-
target eﬀects, new siRNAs (Invitrogen) targeting diﬀerent
sequences among the 21 best candidate genes were tested. As
shown in Table 1, 12 of the new siRNAs signiﬁcantly (P<
.05)increased HGT, thestrongest stimulation being achieved
with the ATF7IP (4.2 ± 0.9) and EP300 (4.2 ± 1.7) siRNAs.
We further characterized these two genes. Interestingly, they
have been described as transcription factors and are involved
in chromatin remodeling [56–59]. RT-PCR analysis showed
that the expression of these genes was knocked down by
both siRNAs (Figure 5). ATF7IP and EP300 mRNA levels
were strongly decreased or undetectable in the presence of
their cognate inhibitors, whereas no eﬀect on GAPDH gene
expression was observed. Importantly, these siRNAs had
no eﬀect on meganuclease expression, demonstrating that
downregulation of the ATF7IP and EP300 genes had no
impact on I-SceI expression.
Altogether, the stimulating activities on HGT, obtained
for siRNAs with two cellular models and with sequences of10 Journal of Nucleic Acids
Table 1: Validation of the candidate genes. Candidate genes were selected after secondary screening. siRNAs targeting various mRNA
sequences were tested for their ability to stimulate homologous gene targeting. Results are the means of at least 3 independent experiments.
siRNA target Mean stimulation factor Std P value
ATF7IP 3.6 1.0 <.05
EP300 3.0 0.9 <.05
SERPINB2 2.5 1.1 <.05
NDUFV1 2.2 0.6 <.05
LRDD 2.0 0.6 <.05
ATR 2.0 0.7 <.05
POP7 1.8 0.6 <.05
FLJ35695 1.8 0.2 <.05
DCDC2 1.6 0.6 <.05
RBP1 1.5 0.2 <.05
LIFR 1.5 0.6 <.05
EFEMP2 1.4 0.2 <.05
USP20 1.4 0.73 >.05
TRIM3 1.4 0.67 >.05
TOP1 1.3 0.5 >.05
HUWE1 1.3 0.3 >.05
SPRED3 1.3 0.6 >.05
C9orf85 1.2 0.8 >.05
LRRC16 1.1 0.58 >.05
CCDC46 1.0 0.3 >.05
KIF7 0.9 0.4 >.05
diﬀerent origins demonstrate the potential involvement of
the corresponding genes on DSB-induced HGT regulation.
3.4. Knockdown of ATF7IP and EP300 Can Stimulate
Meganuclease-Induced Gene Targeting in Endogenous Human
Loci. For validation of the ability of the ATF7IP and EP300
siRNAs to increase HGT frequency at an endogenous locus
in human cells, we used a meganuclease cleaving the human
RAG1 locusdescribed ina previousstudy [55]. The principle
of the targeting experiment is described in Figure 6(a).
Using triple transfection with the donor repair plasmid, the
meganuclease-encoding vector, and siRNA, we determined
the frequency of targeted homologous recombination events
with a PCR screen, as previously described [55]. This
PCR screen has been validated by the characterization,
by Southern blotting, of positive clones from independent
experiments, with no false positive identiﬁed among more
than 50 clones (data not shown). Under the experimental
conditions described here, gene targeting events at the RAG1
locus were detected in 0.7% of the transfected cells in
the presence of the control siRNA (AS). By contrast, the
introduction into the cells of the siRNA targeting the EP300
gene resulted in an increase by a factor of 1.5, whereas siRNA
directed against the ATF7IP gene increased the frequency of
gene targeting events by a factor of 3.5 (Figure 6(b)).
Given the strong eﬀect of the ATF7IP siRNA, we also
assessed its impact on HGT at the human XPC locus. In this
case, we used the XPC4meganuclease, which is an optimized
version of the XPC.c meganuclease described in a previous
study [60]. As the frequency of DSB-induced recombination
was lower at this locus(data not shown), we did not measure
the absolute frequency of HGT. Instead, we measured the
frequency of HGT among stable transformants: the rate of
HGT versus RI of the repair matrix. This rate is used in
many studies in which the absolute frequency of HGT is
low, in plants [61]o rm a m m a l i a ns t e mc e l l s[ 40, 62], for
example. The experimental scheme is shown in Figure 7.
We used a neomycin resistance (NeoR) cassette to select
for transformants. G418-resistant clones were picked two
weeks after transfection, ampliﬁed and characterized at
the molecular level. Two independent experiments were
conducted (Table 2). In the ﬁrst, we obtained 5 targeted
clones (4.2%) from 120 transformants in the presence of
the AS siRNA and 15 clones (10.3%) from 146 transfor-
mants with the knockdown of ATF7IP expression. A second
experiment performed in duplicate gave similar results,
with 2 or 1 (2.4 or 1.3%) targeted clones from 83 or 73
transformants with AS, respectively, and 17 or 6 (14.9 or
10.3%) targeted clones from 114 or 58 transformants with
the ATF7IP siRNA, respectively. These results indicate that
siRNAs shown to increase I-SceI-induced gene targeting
eﬃciency also increase the eﬃciency of homologous gene
insertion induced by engineered I-CreI meganuclease at a
natural locus.
Taken together, these data show that ATF7IP and EP300,
two genes involved in transcription regulation and chro-
matin remodeling [56–59], can be considered as validated
targets, at least for immortalized cells. Indeed, transient
inactivation of these two genes may stimulate HGT at up to
four diﬀerent loci in human cells: the two endogenous loci,Journal of Nucleic Acids 11
Table 2: Eﬀect on gene targeting at the XPC4 locus of an siRNA targeting the ATF7IP gene.
siRNA Number of G418R clones Number of PCR+ clones HGT (%) Fold stimulation
Experiment 1 AS 120 5 4.2
ATF7IP 146 15 10.3 2.4
Experiment 2 AS 83 2 2.4
ATF7IP 114 17 14.9 6.2
Experiment 3 AS 73 1 1.3
ATF7IP 58 6 10.3 7.9
Cells dispensed at density of 2 cells/plate (10cm)
Cleavage site
Ex9 Ex8 Ex10
Transfection with meganucleases and repair substrate
Analysis of gene targeting events by speciﬁc PCR
72h
1week (with G418 selection)
1week (w/o selection)
Picking of clones and ampliﬁcation
1.9kb F3 R1
pCMV-NeoR
pCMV-NeoR
Figure 7: Targeted integration at the endogenous XPC4 locus:
experimental design. The XPC4 target sequence is located in exon
9 of the XPC gene. Exons 8, 9, and 10 are shown in white
boxes. Cleavage of the native XPC gene by the meganuclease yields
a substrate for homologous recombination, which may use the
repair plasmid depicted. Targeted integration events were detected
by genomic PCR ampliﬁcation carried out on neomycin-resistant
clones.
hRAG1 and hXPC4, and the two endogenous luciferase and
GFP reporter loci (from the primary and secondary screen).
Moreover, HGT was stimulated in three diﬀerent cell types
(GM00847, a HEK293derivative, and 293H). Knockdownof
ATF7IP, the strongest candidate, gave a 3.5 times increase
in HGT at the human RAG1 l o c u sa n da nu pt o7t i m e s
increase at the XPC locus. EP300 is a histone acetylase that
acetylates all four core histones in nucleosomes [63], thereby
generating an epigenetic tag for transcriptional activation.
ATF7IP is involved in histone methylation, another type of
transcription-related epigenetic modiﬁcation [56, 64]: it is
required to stimulate the histone methyltransferase activity
of SETDB1 [57]. SETDB1 was not among our primary hits,
but it gave a 1.7 times increase in Z-score value in our
primary screening (data not shown), indicating a stimu-
latory eﬀect on the I-SceI-induced HGT luciferase signal.
Altogether, these results suggest that chromatin remodelling
may be an important mechanism regulating DSB-induced
gene targeting. The exact mechanism of action of ATF7IP
and EP300 knockdown in HGT regulation remains to be
determined.
4.Conclusion
In this study we developed a two-step screening allowing
the detection of factors modulating the eﬃciency of I-SceI-
induced HGT. We screened an siRNA collection targeting
19,000 genes. This led us to the identiﬁcation of 64
genes which down regulation stimulate DSB-induced HGT
frequency. For twelve of the genes we could rule out an
oﬀ-target eﬀect since an siRNA targeting the same gene
but with a diﬀerent sequence could still stimulate HGT
frequency. Surprisingly, the gene knockdowns having the
strongest impact on the eﬃciency of DSB-induced HGT,
ATF7IP, EP300, are not involved in DNA-DSB repair but
rather are implicated in chromatin remodelling. These data
suggest an important role of these mechanisms in regulating
DSB-induced gene targeting. Further characterizations of
these genes would be very valuable to determine if their
downregulation could still stimulate gene targeting not
induced by a DSB as well as any other HR mechanisms (such
as intra- or interchromosomal HR) induced or not by a
double-strand break.
In addition, several other candidates not involved in
chromatin remodeling, such as ATR, LRDD, SERPINB2,
UREB1,a n dTOP1, were selected after secondary screening.
It will therefore be important to assess the eﬀect of these
siRNAs on meganuclease-induced HGT at other loci. Thus,
it seems likely that several other enhancers of HGT could
be identiﬁed by further experiments. In principle, factors
stimulating HGT by diﬀerent mechanisms should have
synergistic eﬀects, making it possible to achieve much higher
levels of stimulation.
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